Tuesday, November 24, 2020

#Cannabis #Stocks up for Episode 500 of Investor Ideas #Potcasts, Cannabis News and Stocks on the Move; (TSX: $FAF.TO) (CSE: $BAMM.C) (NYSE: $ACB) (TSX: $TGOD.TO) (NASDAQ: $CGC)

#Cannabis #Stocks up for Episode 500 of Investor Ideas #Potcasts, Cannabis News and Stocks on the Move; (TSX: $FAF.TO) (CSE: $BAMM.C) (NYSE: $ACB) (TSX: $TGOD.TO) (NASDAQ: $CGC)

 


Delta, Kelowna, BC, November 24, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/112420-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/11241FAF-BAMM-ACB-TGOD-CGC.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we will be looking at a few private and public company announcements.

 

Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ), a multi-state cannabis operator, and Her Highness, a growing cannabis brand designed to introduce and educate women around cannabis, announced today the launch of Her Highness in Nevada through their production licensing agreement.

 

Her Highness will launch Quarantine Queen, a 20-pack of indoor-grown pre-rolls and the brand's fan-favorites Giggle and High Priestess Vape Pens. Her Highness Lip-Logo canvas totes will be complimentary with purchases at select dispensaries.

 

Also launching in Nevada through the BaM partnership is Her Highness' Last Prisoner Project Pre-Roll collection: individual pre-roll and lighter sets that portray the moving stories of one of three women who were incarcerated due to non-violent cannabis offenses. Proceeds from the Last Prisoner Project Pre-roll collection support women with cannabis convictions who are working to be released from prison or re-entering after release.

"We're excited to partner with Her Highness as the Nevada cannabis market continues to see strong increases in year over year sales," stated Michael Mills, CEO of Body and Mind. "Our new production facility combined with our strong distribution platform offers a turn-key opportunity for Her Highness to grow their innovative brand in the expanding Nevada market."

 

Already retailing throughout California, Her Highness is a cannabis lifestyle brand built with a goal to capture the female cannabis market. With an elevated range of thoughtfully reimagined cannabis products for enjoyment and self-care, Her Highness satisfies every woman's cannabis curiosity and craving.

 

"We're thrilled to be launching with Body and Mind as our partner in Nevada. Known for dedication to quality and effective market penetration, they really understand our brand and passion for our mission," stated Allison Krongard, co-founder of Her Highness. "The level of commitment to detail and support we've  seen already tells us we're on a path to success in this excting market."

 

Her Highness co-founders, Laura Eisman and Allison Krongard, set out to fill the gap in the market with a premium cannabis experience that was infused with a sense of play and delivered with style.

 

"The Body and Mind collaboration kicks off Her Highness' expansion beyond California into additional legal markets throughout the US and internationally," commented Laura Eisman, co-founder of Her Highness. "BaM was quick to recognize Her Highness' potential in the Nevada market, specifically in Las Vegas, a city sure to embrace the brand's bold and glamorous approach and undeniable appeal to women."

 

Through the partnership with BaM, Her Highness' line of cannabis products are now available at dispensaries throughout Nevada. https://bamcannabis.com/nevada/

 

Fire & Flower Holdings Corp. (TSX: FAF) and its wholly-owned subsidiary Fire & Flower Inc. announced that its stores will once again offer free best-in-class home delivery and curbside pick-up to safely and responsibly service its customers during the newly-mandated Toronto and Peel region lockdown in the Province of Ontario.

 

Beginning Monday, November 23, customers can easily order their cannabis products from Fire & Flower's Toronto locations using the e-commerce platform at www.fireandflower.com and choose between either free same-day delivery to their homes or to come to their nearest store for curbside service, ensuring the health and safety of Fire & Flower customers and team members.

 

On Friday, November 20, 2020, Attorney General Doug Downey approved an emergency order placing the Toronto and Peel regions under a new lockdown to combat COVID-19.  On Sunday, November 22, 2020, Ontario Regulation 654/20 was made allowing cannabis retail stores located in the lockdown regions to operate through e-commerce, curbside pickup and home delivery services.  Fire & Flower's Toronto locations are poised to continue operations through e-commerce and commence curbside and delivery services immediately.

 

"We applaud Attorney General Doug Downey for the practical solution of allowing provincially-licensed cannabis retailers the same e-commerce abilities of delivery and curbside pick-up that all other retailers have during this period of lockdown," said Trevor Fencott, Chief Executive Officer, Fire & Flower. "This act allows us to safely provide service to our customers and continue to combat the burgeoning illegal market during these challenging times."

 

"As the legal industry steps up for the second time and invests in safe delivery for our customers, we hope the Provincial government will recognize that the Ontario Cannabis Store's monopoly on delivery is an unnecessary burden on public health, taxpayers, customers and economic growth in the Province" continued Fencott. "Lockdowns will eventually end, but the road to economic recovery for private business will be difficult and the large illegal market will continue unchallenged unless the government makes these changes permanent.  Our customers expect e-commerce and delivery options from every other kind of retailer in the Province, and deserve to receive equitable treatment for licensed cannabis retailers."

 

Fire & Flower and Hifyre™ digital teams are re-establishing the operating procedures and technology that served safely customers through online payment, curbside pickup and home delivery services earlier this year when the province was initially combatting the pandemic. 

Fire & Flower has a distinct competitive advantage as online ordering, curbside pickup and delivery become available through its ability to communicate with almost 178,000 members in the Spark Perks program on the Hifyre™ digital platform. The Spark Perks program provides a robust channel to communicate with consumers, understand their needs and preferences and drive consumer traffic digitally.

 

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), a leading producer of premium certified organically grown cannabis, announced that it has received an Export Certificate from Health Canada.  This certificate enables TGOD to complete its first shipment of medical cannabis to Germany where it will undergo stability testing, the last step before the Company can commence commercialization in 2021.

 

"This is an important milestone as we get ready to begin the international shipping of our certified organically grown medical cannabis products.  Germany is the first of several markets that we are planning to supply.  Other countries that we anticipate shipping to in the future are Australia and Mexico," commented Sean Bovingdon, Interim CEO of TGOD.  "We chose to obtain our EU-GMP certification from Germany because of its high standards and its progressive medical cannabis framework," added Bovingdon.

 

Lastly we look at comments from the www.WallStreetReporter.com from both Aurora Cannabis (NYSE: ACB) (TSX: ACB) CEO, Miguel Martin, who said Aurora is now “Focused on Delivering ‘Quality Revenue’ through Premium Brands” and Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED), CEO David Klein who discussed how “Momentum is Building - On Path to Profitability”

 

CEO, Miguel Martin commented, “...the consumer has demonstrated very dynamic tendencies with market share moving very quickly between brands, unlike in more stable CPG categories. This provides us with a great opening for our pivot to premium brands….Data from Canada and other mature markets indicate that premium and super premium brands have been and will continue to be successful in all formats. Therefore, Aurora has a real opportunity for a more articulated and balanced portfolio offering with a greater focus on higher margin and sustainable premium assets, such as vapes, pre-rolls and premium flower offerings across multiple price tiers....

 

We are also working to expand our leading concentrates and to refocus our dried flower business toward higher gross profit dollar pools...The key of course, is to ensure that in doing so we are delivering more dollars to the gross profit line versus simply just delivering low margin revenue. We are therefore much more interested in our market share within premium and super premium categories, along with our market share of categories, such as vapor, pre-rolls and concentrates that are margin accretive compared to our market share in the deep discount flower business...our intention is to generate not just revenue but quality revenue, that will deliver a healthy gross profit dollar as opposed to essentially just a gross margin percentage.”

 

CEO David Klein commented, “...Momentum is building across our key businesses as our new strategy is coming to fruition. We achieved record quarterly revenue in Q2 led by our Canadian recreational business and strength across our strategic businesses, including Storz & Bickel, This Works in BioSteel...We’re continuing to improve execution and agility. Our fill rates are now consistently exceeding 90%, our flower quality improvement program is generating positive results, and we’ve improved our new product development process to allow us to bring better products to market faster...We’re accelerating our path to profitability, notably in our largest market, Canada...I’m confident that we’re now firmly on a path to achieve positive adjusted EBITDA at some point next fiscal year.”

 

“We’re building a portfolio of scalable brands across cannabis and CPG. Our goal is to become a cannabis-focused CPG company. We’re bringing our THC brands such as Tweed and Houseplant into the U.S. market through multi-state operator relationships or CBD line extensions. We’re growing new-to-world CBD brands, such as Martha Stewart, to meet consumer needs. We’re establishing routes to market with our CPG brands such as BioSteel, This Works, and Storz & Bickel. These are strong brands in their own right with distinct value propositions. Building these brands today allows us to generate revenues without the headwinds of regulatory challenges. And then, we plan to line extend these brands into CBD or even THC as regulations evolve.We will layer in additional brands over time, which will create further scale with our existing distribution networks and further build our relationships with retailers...”

 

 

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800 665 0411

 

 


  

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

 

Friday, November 20, 2020

Investorideas.com - Psilocybin Stock News: Red Light Holland (CSE: TRIP) and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market

Investorideas.com - Psilocybin Stock News: Red Light Holland (CSE: TRIP) and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 499: (TSX: $DN.TO) (NASDAQ: $VFF) (TSX: $VFF.TO) (CSE: $CURA.C)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 499: (TSX: $DN.TO) (NASDAQ: $VFF) (TSX: $VFF.TO) (CSE: $CURA.C)

 


Delta, Kelowna, BC, November 20, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/112020-StocksToWatch.mp3

 

Read this in full at

https://www.investorideas.com/news/2020/cannabis-potcasts/11201DN-VFF-CURA.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we will be looking at a few private and public company announcements.

 

DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) announced that it has completed its final services milestone under an agreement with Ahahswinis Green Investments Ltd (“Ahahswinis”) which is 100% owned by Hupacasath First Nation. Ahahswinis is an arms length third party in which Delta 9 has no ownership control or interest.

 

As one of Delta 9’s micro cultivation partners, Ahahswinis entered into a Strategic Cooperation Agreement (“SCA”) with the company whereby Delta 9 provides services relating to the cannabis production facility design and construction, development of standard operating procedures and sanitation programs, consulting on Health Canada licensing, and other services supporting the acquisition of the Health Canada license. On November 13, 2020, Ahahswinis confirmed it has reached its final milestone under the SCA and has been granted a cannabis micro cultivation license from Health Canada (the “Health Canada License”).

 

“We are pleased with having achieved this major milestone in our agreement with Ahahswinis and thrilled that they are the first Delta 9 micro cultivators in Canada to be 100% wholly owned by a First Nation and receive a Health Canada Licence for our proprietary and turn-key 'Grow Pod' systems”, said John Arbuthnot, Founder and CEO of Delta 9. “We are continuing to work with First Nations in Canada to develop our micro cultivation services so that our platform can be the "go to" platform for cannabis entrepreneurs looking to produce premium quality cannabis products.”

 

The Company's cannabis production methodology is based around a modular, scalable, and stackable production unit called a "Grow Pod", which are retrofitted standard 40-foot shipping containers. Ahahswinis’s facility has been designed and built using this turn key and state of the art Grow Pod system. Once cultivation begins, Delta 9 plans to purchase premium quality cannabis products from Ahahswinis for distribution through the Company's established distribution network, and through Delta 9's branded retail stores.

 

“I would like to thank Delta 9 for providing us with a turn-key platform to grow cannabis and for their continued support as we begin production in December 2020", said James Tatoosh, President. "Their proven grow pod design made it easier to receive a Health Canada license and apply and receive funding from the Nuu Chah Nulth Economic Development Corp. (NEDC). We look forward to being a part of this new industry producing small batch, premium grown, craft cannabis.”

 

The Hupacasath First Nation has owned and occupied their traditional territory in Central Vancouver Island for thousands of years. Their goal is to enhance the quality of life for their people by providing jobs and economic development opportunities so families can support themselves. They have invested $1.9 million in the 4,560 square foot micro cultivation operation with 12 Delta 9 Grow Pods, located outside of Port Alberni Vancouver Island, British Columbia.

 

Pure Sunfarms, the wholly owned subsidiary of Village Farms International Inc. (NASDAQ: VFF) (TSX: VFF), announced that their brand will be appearing as part of a limited-edition Lane Crawford x Found CBD-infused gift set to be sold in the luxury department store’s holiday pop-up shops in Hong Kong. This is Pure Sunfarms first international appearance as a leading Canadian cannabis brand.

 

Pure Sunfarms’ brand’s appearance on the international stage stems as a result of a partnership between Altum International Limited’s Found, Asia-Pacific’s first CBD retail platform and cafĂ©, and Lane Crawford, an iconic luxury department store in Greater China. The co-branded holiday pop-up shops aim to educate consumers and elevate their awareness about CBD.

 

Luxury gift sets available for purchase at the pop-up shops will feature Pure Sunfarms’ CBD gummies created specifically for the Hong Kong consumer, among other CBD-inspired items such as chocolates, bath salts, and tea bags.

 

“We’re so pleased for the Pure Sunfarms’ brand to make its debut internationally, alongside such prestigious and progressive partners as Altum and Lane Crawford,” said Mandesh Dosanjh, President & CEO, Pure Sunfarms. “This is just the beginning of what’s to come for Pure Sunfarms as we look to share our love our plants and B.C.-grown cannabis products with the global cannabis market.”

 

“We are particularly excited to be able to present in Asia-Pacific for the first time, Pure Sunfarms, Canada’s market leading cannabis brand,” Fiachra Mullen, Chief Marketing Officer for Altum International. “We believe that the leading cannabis brands in the Canadian market will hold a special place in the Hong Kong consumer’s heart. We are incredibly proud to have their trust in helping them access the Asia-Pacific markets for the first time through the most progressive cannabinoid jurisdiction in the region - Hong Kong.”

 

The pop-up shops will run from November 13 through to the end of December 2020 at Lane Crawford’s ifc mall, Canton Road and Times Square locations.

 

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading U.S. provider of consumer products in cannabis, announced today the launch of its NANO Chews product in the Florida market. Curaleaf's sugar-free, fast-acting NANO Chews offer a reliable and consistent cannabis experience and are available at Curaleaf's retail locations across the state, including the two newest dispensaries which recently opened in Pensacola and Panama City.

 

Utilizing nano-emulsion technology, Curaleaf NANO Chews are ideal for patients seeking a faster onset time and more calibrated experience. With 5mg of THC per piece, NANO Chews are infused with small, water-soluble cannabinoids. This technology allows patients to feel the product's full effects in roughly half of the time of a traditional edible. NANO Chews are typically preferred among patients who are looking for quicker relief than traditional edibles offer. Curaleaf NANO Chews are available in the sugar-free flavor of Arctic Berry at launch, with additional flavors to follow, and Classic Chews, a more traditional edible, are also expected to launch in Florida in the coming weeks. Per Florida state regulations, the product does not contain any natural or artificial color additives.

 

Florida's Department of Health officially authorized medical applications of edibles in September. Prior to the announcement, Curaleaf released a selection of premium products in Florida, including first-to-market Sublingual Tablets, Select Elite Live cartridges, and RSO. Since then, the Company has debuted both NANO Drops and Live Blends in Florida, all of which cater to a variety of patient preferences.

 

"We're thrilled to bring NANO Chews to Florida," said Joe Bayern, President of Curaleaf. "This is the next step in delivering true innovation to the market. After receiving incredible feedback from patients in states where NANO Chews have already launched, we are confident that Floridians who've waited nearly four years for edibles will embrace a new kind of cannabis experience with NANO Chews."

 

Florida is an increasingly fast-growing medical marijuana market in the United States with over 430,000 registered medical patients. Curaleaf currently operates 33 dispensaries in Florida and 95 dispensaries nationwide. To see Curaleaf's dispensary locations in Florida, along with hours of operation and contact information, please visit www.curaleaf.com/locations/#florida.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

Thursday, November 19, 2020

Investorideas.com - Beverage / Cannabis Stock News: Hill Street (TSXV: BEER) Announces Definitive Agreement to Acquire Assets of Lexaria Canpharm, and Closing of Private Placement

Investorideas.com - Beverage / Cannabis Stock News: Hill Street (TSXV: BEER) Announces Definitive Agreement to Acquire Assets of Lexaria Canpharm, and Closing of Private Placement

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 498: (TSX: $CWEB.TO) (TSXV: $PCLO.V) (TSXV: $BEER.C) (CSE: $LXX.C)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 498: (TSX: $CWEB.TO) (TSXV: $PCLO.V) (TSXV: $BEER.C) (CSE: $LXX.C)

 


Delta, Kelowna, BC, November 19, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/111920-StocksToWatch.mp3

 

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/11191CWEB-PCLO-BEER-LXX.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Today’s podcast overview/transcript:

 

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

 

In today’s podcast we will be looking at a few private and public company announcements.

 

Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX:CWBHF), the market leader in  hemp CBD extract products, announced a collaboration between its CW Labs science division and the University at Buffalo's  Center for Integrated Global Biomedical Sciences to advance hemp cannabinoid science through a research program that provides a better understanding of the therapeutic uses and safety of cannabinoids.

 

This new scientific initiative builds on early projects that have been envisioned with Dr. Gene D. Morse, Director of the Center for Integrated Global Biomedical Sciences (CIGBS) at the University at Buffalo and State University of New York (SUNY) Distinguished Professor. The new partnership includes collaboration on a global program to advance cannabinoid sciences implementation research and safety for both supplement and biomedical use of cannabinoids with the coordination center at Buffalo, N.Y. Its purpose is to identify optimal approaches to advance the safe use of cannabinoid-containing products and identify the gaps in current knowledge. The program will include the design and implementation of novel population-based clinical informatics analysis using large databases, pilot projects that facilitate better understanding of pre-clinical and clinical pharmacology, and drug interactions to develop safe approaches to cannabinoid therapy.

 

"Charlotte's Web's CW Labs has an advanced team of scientists based here on the medical campus.  We are excited to work with the clear leaders in the hemp sector, both in the quality of their hemp genetics and their products," said Dr. Morse.

 

"We realize the value of partnering our established cannabinoid product business models with an internationally recognized leader in clinical research to address the growing field of cannabinoid health and wellness products," said Tim Orr, CW Labs' Senior Vice President of Innovation. "This collaboration will oversee multidisciplinary teams conducting cutting edge research in new areas of implementation to expand the database of evidence that can guide future therapeutics development in the field. We are pleased to have established this working relationship with UB's Center for Integrated Global Biomedical Sciences and the opportunity that this new alliance creates."

 

Building of this multi-disciplinary team is underway. It includes UB investigators: Dr. Laszlo Mechtler, a Neurologist and Neuro-oncologist in the department of Neurology, Medical Director of the Dent Neurologic Institute and it's Cannabis Clinic and Research Center, as well as the Chief of Neuro-Oncology at Roswell Park Comprehensive Cancer Center, Dr. Jason Sprowl, a pharmaceutical scientist in the department of Pharmaceutical Sciences at UB,  investigators at the University of the West Indies, Mona Campus, Jamaica,   Dr. Marvin Reid, director of the Tropical Medicine Research Institute, Professor Thejani Delgoda, who leads the Natural Products Institute, and Professor Wendel Abel of Community Health and Psychiatry. At the University of Zimbabwe, Professor Charles Maponga, Director of the Clinical Pharmacology Laboratory, is engaged with planning clinical research and related regulatory policies to promote safe cannabinoid use.

 

The collaboration will pursue implementation research related to the wellness aspects of cannabinoids through the established national and global capacity-building efforts that form the foundation of the UB Center for Integrated Global Biomedical Sciences. This includes programs that have been developed with the Dent Neurologic Institute, home to one of the nation's largest and most comprehensive physician-directed medical cannabis programs with more than 15,000 active patients, the University of the West Indies, Mona Campus in Jamaica, and the University of Zimbabwe Center of Excellence in Pharmaceutical Innovation in the developing Health Galaxy Park site in Harare, Zimbabwe. The goal is to build a global collaboration of partners with an interest in cannabinoid sciences that includes pre-clinical and translational pharmacology, human safety, and community-based health informatics.

 

"These scientists bring global expertise in areas such as cellular transport mechanisms that influence cannabinoid distribution throughout the body, clinical pharmacology mechanisms that contribute to different responses among individuals and potential interactions between botanical cannabinoids and commonly used medications and will contribute to a global understanding of cannabinoids" said Dr. Morse.

 

Dr. Morse, and Dr. Jeffrey C. Lombardo, Program Coordinator for Global Cannabinoid Sciences, will lead the collaboration with CW Labs. Dr. Morse, Director of the Translational Pharmacology Research Core and co-Director of the Drug Development Center at UB, has extensive experience with pharmacologic assay development, designing, implementing and analyzing clinical trials with pharmacokinetics and pharmacodynamics. The collaboration with CW Labs Inc. will create a novel partnership with the Global Cannabinoids Research program at the Center for Integrated Global Biomedical Sciences.

 

PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) and MINO Labs S.A. de C.V., the founders of PharmaCielo S.A. de C.V., congratulate Mexican Senate members for advancing the much-needed cannabis legislation and subsequent reform by voting to move forward the legalization bill, which includes provision for import of medicinal extracts and products.

 

David Attard, CEO of PharmaCielo Ltd., says, "The recent vote is an important development and positive momentum toward bringing cannabis reform to the finish line by the mid-December deadline. The partnership we established with MINO Labs last year as PharmaCielo Mexico is a precursor to what we expect will become an important and vibrant market for cannabis-derived health and wellness products, for which we aim to become a primary supplier of high-quality medicinal-grade oils and isolates."

 

Manuel Cosme Odabachian, CEO of MINO Labs, stated, "Mexican lawmakers made it loud and clear today that adult cannabis usage should be legalized. The Senators' votes in favor of the new bill are a huge step forward and a development welcomed by both end-users and industry participants. For the past 20 years, MINO Labs has been a leading specialty supplier and distributor of pharma-grade products in Mexico. Together with PharmaCielo we have built a great infrastructure to provide the Mexican market with top-notch cannabis extract product offerings – and we are ready to deliver!"

 

PharmaCielo and MINO Labs founded PharmaCielo Mexico last year as a joint venture. The purpose of the joint venture is to bring PharmaCielo's high-quality cannabis extracts and derivative products from its Colombian cultivation and processing centre to the Mexican market by leveraging MINO Labs' extensive experience and broad presence in the country's pharma distribution space. Upon completion of the legislative process, PharmaCielo Mexico will commence the sale and distribution of medicinal cannabis products, including those for wellness and lifestyle segments, in Mexico.

 

Distribution of cannabis products by PharmaCielo in Mexico will be subject to the approval of the TSX Venture Exchange (the "TSXV").

 

Hill Street Beverage Company Inc. (TSXV: BEERannounced that it has signed a definitive agreement to acquire the primary assets of Lexaria Canpharm, the cannabis-related division of Lexaria Bioscience Inc. (CSE: LXX). This acquisition provides Hill Street with the exclusive rights in perpetuity to use Lexaria's ground-breaking DehydraTECHTM patent portfolio on a global basis to make any type of products containing THC and other psychoactive cannabinoids. In addition, the agreement expands Hill Street's license with Lexaria HempCo to make products containing CBD on a global basis for ten years.

Terms of the acquisition

       Total consideration of $3.85 million, including $350K in cash upon closing and future payments of $2.0 million.

       Hill Street will issue Lexaria Bioscience a total of $1.5MM worth of Common Shares in the capital of the Company in three equal installments with the first tranche issuable on closing. The first tranche will be issued at a price of $0.0829 per share, which is equal to the 10-day volume weighted average closing price of the Common Shares on the TSX Venture Exchange on the date hereof. All successive issuances shall be issued at the greater of (A) the 10-day volume weighted average closing price of the Common Shares on the TSX Venture Exchange on such payment date; and (B) $0.0829;

 

With over sixty patents for DehydraTECHTM either issued or pending, this transaction positions Hill Street to expand its strategy of producing ingredients for Cannabis 2.0 products, allowing the Company to take advantage of growing demand for "quick onset and duration" recreational cannabis edibles and topicals. This transaction will allow Hill Street to expand its addressable market to every country in the world where cannabis is either medicinally or recreationally legal. Lexaria's Intellectual Property converts perishable cannabis products such as oils and extracts into shelf stable powders. Hill Street will manufacture these powders for sale to licensed cannabis processors at its own facility as well as sub-license the technology to licensed manufacturers globally. Shelf stable cannabis powders are the ideal ingredients upon which to build world class Cannabis 2.0 brands, including beverages, edibles, and topicals. The DehydraTECHTM processes are well researched, market validated, and well protected through multiple patents, and will continue to improve as Lexaria continues its research.

 

Completion of the transaction is subject to the approval of the TSX Venture Exchange.

 

"With this transaction, we are building on an already strong partnership with Lexaria. We are gaining full ownership of the joint manufacturing partnership we created last year, and positioning Hill Street to become an early leader in the global market for cannabis 2.0 ingredients and products. Our cannabis processing facility is designed specifically to produce shelf stable ingredients using DehydraTECHTM for the Cannabis 2.0 market," said Terry Donnelly, Chairman & CEO of Hill Street. "With a significant portion of the consideration in shares and future payments, this transaction demonstrates Lexaria's faith in Hill Street to unlock the value of their innovations for their shareholders based on our success."

 

"Hill Street's team is executing a new and exciting strategy in the cannabis sector, designed to take advantage of the Cannabis 2.0 market and enhanced consumer expectations," stated Chris Bunka, Chairman & CEO of Lexaria Bioscience. "Their deep expertise in consumer goods will allow consumers to experience Lexaria's innovations through the highest performance products available in the Cannabis 2.0 sector. Lexaria's focus remains on creating the greatest innovations possible in drug delivery in the diverse sectors of nicotine, cannabinoids, and antivirals for both the therapeutic and pharmaceutical industries. Innovations in drug delivery in the pharmaceutical industry represents a massive global opportunity for Lexaria, and this transaction with Hill Street assists our ability to focus, while providing our shareholders with a significant carried interest in a fast growing startup well positioned for success in the cannabis 2.0 market."

 

Canndora, the global media and event platform, and initiative created by Marigold Marketing & PR to support advancing women in emerging industries has announced it is hosting #CanndoraConnect: Women in Psychedelics event.

A virtual event, #CanndoraConnect: Women in Psychedelics is open to audiences worldwide and will take place 2:00-4:00 p.m. EST on Wednesday, December 2nd, 2020. The event will offer attendees a unique experience, providing collaboration, networking, inspiration, and advice for women's success in the emerging psychedelics industry worldwide.

“We are honoured to be partnering with Canndora to create a movement that is bringing awareness and attention to advancing women in the emerging psychedelics industry,” says Todd Shapiro, CEO & Director of Red Light Holland. “This is an exciting event that will provide amazing opportunities to network, learn, connect and feel inspired by all of the extraordinarily intelligent speakers and panellists, including Ann Barnes and Sarah Hashkes, whom we are proud and grateful to work so closely with at Red Light Holland.”

Attendees will hear from influential speakers, learn best industry practices for success, and network with leading industry experts in psychedelics. The event will feature notable industry professionals and panelists who will share their expertise on critical topics, including opportunities for international business in psychedelics and the science behind psilocybin and its role in women's health.

Industry leaders and speakers in attendance include:

      Ann Barnes, Director of Red Light Holland

      Sarah Hashkes, CEO of Radix Motion

      Terri Smith, Chief Mycologist of WAKE

      Dr. Olga Chernoloz, Chief Scientific Officer of WAKE

      Susan Chapelle, President of Havn Life

      Irie Selkirk, Co-founder & Director of Rise Wellness Retreats

“2020 is the year the voice of psychedelic renaissance has been heard the loudest,” says Dr. Olga Chernoloz, Chief Scientific Officer of WAKE. “So far the data streaming from the psychedelic clinical studies has been exceptionally promising. It gives hope to the development and recognition of new treatment modalities for the support of mental health. Women, often disproportionately affected by these conditions, could find a way to re-process the underlying emotional content and find balance with help of the psychedelic-assisted therapy.”

Now hosting its seventh professional event for emerging industries, including sell-out attendance in previous cannabis women-focused events, the #CanndoraConnect: Women and Psychedelics event is positioned to be a hailed success. The event is made possible with support from presenting partners, Red Light Holland (CSE: TRIP) (OTC: TRUFF) and WAKE.

The #CanndoraConnect: Women in Psychedelics event is open to anyone 19+. Tickets are CAD$15.00 and attendees are encouraged to register as soon as possible as spaces are limited. To purchase tickets, register on Eventbrite.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

 

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

 

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 


  


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory